Psychiatry · Fresno, CA
NPI
1023107513
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
8
Medicare group memberships
Hospitals
0
Hospital affiliations
2772 S. Martin Luther King Blvd.
Fresno, CA, 93706
Phone (559) 251-4800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$817K
1,973 prescriptions
Company payments, 2025
$57K
From 12 companies
Medicare prescription drug claims, 2024
In 2024, the drug Herbert A Cruz prescribed most often to Medicare patients was Quetiapine Fumarate, with 131 prescriptions and refills. In total Herbert A Cruz wrote 1,973 Medicare prescriptions that cost $817K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Quetiapine Fumarate Generic | 131 | 132 | 13 | $6,365 |
| Clonazepam Generic | 114 | 117 | 12 | $1,645 |
| Risperidone Generic | 105 | 106 | Under 11 | $3,782 |
| Aripiprazole Generic | 101 | 102 | Under 11 | $3,071 |
| Buspirone Hcl Generic | 87 | 87 | Under 11 | $1,027 |
| Clomipramine Hcl Generic | 73 | 74 | Under 11 | $24K |
| Sertraline Hcl Generic | 72 | 72 | Under 11 | $652 |
| Topiramate Generic | 66 | 67 | Under 11 | $3,160 |
| Fluvoxamine Maleate Generic | 66 | 67 | Under 11 | $8,906 |
| Divalproex Sodium Generic | 63 | 64 | Under 11 | $5,562 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 62 | 63 | Under 11 | $102K |
| Divalproex Sodium Er Divalproex Sodium | 61 | 62 | Under 11 | $7,442 |
| Clozapine Generic | 60 | 60 | Under 11 | $4,266 |
| Asenapine Maleate Generic | 58 | 58 | Under 11 | $31K |
| Paroxetine Hcl Generic | 55 | 55 | Under 11 | $714 |
Brand drugs: 231 claims; generic drugs: 1,742 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Herbert A Cruz $57K ($57K in general payments such as food, travel and fees) from 12 companies. The largest payer was Neurocrine BioSciences, Inc. with $54K.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 54 | $54K |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $1,852 |
| Alkermes, Inc. ALKS | 28 | $577 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $264 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 16 | $227 |
| Axsome Therapeutics, Inc. AXSM | 3 | $144 |
| Lundbeck LLC | 3 | $56.75 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $53.73 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $47.37 |
| Braeburn Inc. | 2 | $39.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.